Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.55 USD | +1.11% | +19.42% | -51.13% |
Business Summary
Number of employees: 40
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 13-07-04 | |
Sandra Boenisch
DFI | Director of Finance/CFO | 43 | 15-09-30 |
Edward Hammond
CTO | Chief Tech/Sci/R&D Officer | - | - |
Walter Kaufmann
CTO | Chief Tech/Sci/R&D Officer | - | 19-01-01 |
David Goldberger
LAW | General Counsel | - | Nov. 05 |
Adebayo Laniyonu
PRN | Corporate Officer/Principal | - | 21-05-04 |
Daniel Klamer
PRN | Corporate Officer/Principal | - | 15-08-31 |
Juliana Daley
PRN | Corporate Officer/Principal | 37 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 13-07-04 | |
Tom Skarpelos
FOU | Founder | 57 | 04-01-22 |
Jiong Ma
CHM | Chairman | 60 | 21-05-24 |
Steffen Thomas
BRD | Director/Board Member | 58 | 15-06-14 |
Peter Donhauser
BRD | Director/Board Member | 58 | 17-02-07 |
Director/Board Member | 51 | 18-03-01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 84,641,537 | 82,059,741 ( 96.95 %) | 0 | 96.95 % |
Company contact information
Anavex Life Sciences Corp.
630 5th Avenue 20th floor
10111, New York
+844 689 3939
http://www.anavex.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.13% | 385M | |
+9.42% | 115B | |
+11.84% | 106B | |
-2.68% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- AVXL Stock
- Company Anavex Life Sciences Corp.